Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-4hhp2 Total loading time: 0 Render date: 2024-06-08T08:38:30.011Z Has data issue: false hasContentIssue false

15 - Therapeutic decision making in BMT/SCT for severe aplastic anemia

Published online by Cambridge University Press:  05 August 2013

By
Reinhold Munker ,
Anna Locasciulli  and
Kerry Atkinson
Edited by
Reinhold Munker ,
Gerhard C. Hildebrandt ,
Hillard M. Lazarus  and
Kerry Atkinson
Reinhold Munker
Affiliation:
Louisiana State University, Shreveport
Gerhard C. Hildebrandt
Affiliation:
University of Utah
Hillard M. Lazarus
Affiliation:
Ireland Cancer Center, Case Western Reserve University Hospital, Cleveland
Kerry Atkinson
Affiliation:
University of Queensland
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
The BMT Data Book
Including Cellular Therapy
 , pp. 165 - 171
Publisher: Cambridge University Press
Print publication year: 2013

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Brodsky, RA, Chen, AR, Brodsky, I, et al. 2004. High-dose cyclophosphamide as salvage therapy for severe aplastic anemia. Exp Hematol 32: 435–440.CrossRefGoogle ScholarPubMed
Champlin, RE, Perez, WS, Passaweg, JR, et al. 2007. Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimes. Blood 109: 4582–4585.CrossRefGoogle Scholar
Eapen, M, Rademacher, JK, Antin, JH, et al. 2011. Effect of stem cell source on outcomes after unrelated donor transplantation in severe aplastic anemia. Blood 118: 2618–2621.CrossRefGoogle ScholarPubMed
Frickhofen, N, Heimpel, H, Kaltwasser, JP, et al. 2003. Antithymocyte globulin with or without cyclosporine A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia. Blood 101: 1236–1242.CrossRefGoogle ScholarPubMed
Kennedy-Nasser, AA, Leung, KS, Mahajan, A, et al. 2006. Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia. Biol Blood Marrow Transplant 12: 1277–1284.CrossRefGoogle ScholarPubMed
Locasciulli, A, Oneto, R, Bacigalupo, A, et al. 2007. Outcome of patients with acquired aplastic anemia given first-line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation. Haematologica 92: 11–18.CrossRefGoogle ScholarPubMed
Marsh, JW. 2007. Treatment of acquired aplastic anemia. Haematologica 92: 2–5.CrossRefGoogle ScholarPubMed
Meyers, G & Maziarz, RT. 2010. Is it time for a change? The case for early application of unrelated allo-SCT for severe aplastic anemia. Bone Marrow Transplant 45: 1479–1488.CrossRefGoogle ScholarPubMed
Scheinberg, P, Fischer, SH, Li, L, et al. 2007. Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia. Blood 109: 3219–3224.CrossRefGoogle ScholarPubMed
Scheinberg, P, Nunez, O, Weinstein, B, et al. 2011. Horse versus rabbit antithymocyte globulin in acquired aplastic anemia. N Engl J Med 365: 430–438.CrossRefGoogle ScholarPubMed
Storb, R, Blume, KG, O’Donnell, MR, et al. 2004. Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic transplantation: the experience in four centers. Biol Blood Marrow Transplant 7: 39–44.CrossRefGoogle Scholar
Young, NS, Calado, RT, & Scheinberg, P. 2006. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood 108: 2509–2519.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×